Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration Type 2 diabetes

Diabetic Medicine

Volumn 32, Issue 9, 2015, Pages 1149-1155

  Steven, Sarah ^a   Taylor, R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LIPID; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DIABETIC PATIENT; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME; WEIGHT REDUCTION; BLOOD; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DRUG EFFECTS; HYPERTENSION; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; TIME FACTOR; VERY ELDERLY; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84929100230     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12722     Document Type: Article

References (20)

1. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44: 1249-1258.
2. NICE. CG87 Type 2 diabetes. The management of type 2 diabetes 2010.
3. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-2514.
4. Henry RR, Schaeffer L, Olefsky JM. Glycaemic effects of intensive caloric restriction and siocaloric refeeding in non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1985; 61: 917-925.
5. Steven S, Lim EL, Taylor R. Population response to information on reversibility of Type 2 diabetes. Diabet Med 2013; 30: e135-e138.
6. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
7. Bradley D, Conte C, Mittendorfer B, Eagon JC, Varela JE, Fabbrini E et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest 2012; 122: 4667-4674.
8. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709-1716.
9. Lingvay I, Guth E, Islam A, Livingston E. Rapid Improvement in Diabetes After Gastric Bypass Surgery: Is it the diet or surgery? Diabetes Care 2013; 36: 2741-2747.
10. Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell Function in type 2 diabetic patients. Diabetes 2013; 62: 3027-3032.
11. Yki-Järvinen H. Type 2 diabetes: remission in just a week. Diabetologia 2011; 54: 2477-2479.
12. Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity. Obes Surg 2010; 20: 1245-1250.
13. Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008; 58: 548-554.
14. NICE. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. UK: National Institute for Clinical Excellence, 2006.
15. Clinical guidelines for type 2 diabetes. Blood glucose management. Sheffield: University of Sheffield, The Royal College of General Practitioners Effective Clinical Practice Unit, 2002.
16. Arauz-Pacheco C, Parrott MA, Raskin P. The Treatment of Hypertension in Adult Patients With Diabetes. Diabetes Care 2002; 25: 134-147.
17. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
18. Peters C, Steven S, Taylor R. Reversal of type 2 diabetes by weight loss despite presence of macro-and micro-vascular complications In: Draznin B, ed. Diabetes Case File: Practical Problems, Real Solutions. Alexandria, Viginia: ADA Books, 2014 (in press).
19. Tabák A, Jokela M, Akbaraly T, Brunner E, Kivimäki M, Witte D. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009; 373: 2215-2221.
20. Sattar N, McConnachie A, Ford I, Gaw A, Cleland SJ, Forouhi NG et al. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 2007; 56: 984-991.